Almac Group
20 Seagoe Industrial Estate
Craigavon, BT63 5QD
E: almacanalytical@almacgroup.com
W: Analytical & Solid State Services – Almac

 

The Almac Group is a global leader in providing a range of expert services and support across the drug development lifecycle.

We are trusted experts in R&D, diagnostic services, API manufacture, formulation development, clinical trial supply services and technologies through to commercial-scale manufacture and distribution.

We are recognised as an industry leader in client service, providing understanding, experience and knowledge to our clients as we work together to advance human health.

Almac is trusted by the leading global biopharma companies to provide crucial services across their drug development projects. In the last 5 years alone, we have contributed to over 50% of all FDA approved New Molecular Entities (NMEs) and are currently supporting 25% of EU approved /pre-registered Gene therapy products.

A privately owned organization, Almac has grown organically over the past five decades, employing over 7,500 highly skilled employees across 18 facilities in Europe, North America, and Asia.

SERVICE HIGHLIGHTS

API Services & Chemical Development

Providing integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API), we offer a wide range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and costs through the integration of our services and application of innovative biocatalysis and technology solutions:

• API development and manufacture
• Peptide & Protein Technologies
• Analytical Services
• Physical Sciences
• 14C-radiolabeling
• Biocatalysis solutions
• Continuous flow chemistry
• Non GMP starting materials / intermediates

Pharmaceutical Development

Addressing the increasing pressure to bring clinical candidates through pipelines faster and with greater efficiency, we provide expert solid, oral dose pharmaceutical drug product development solutions.  From developing a fit-for-purpose formulation for First-in-Human trials, to scaling up for late phase trials and ultimately commercialization, our solid oral dose, pharmaceutical development solutions are customized to meet our client needs.

• Pre-formulation
• Non-GMP development
• Early-stage development
• Scale-up and later stage development
• Clinical trial manufacture
• High potency processing
• Analytical support

Commercial Services

Meeting all your commercial needs, we provide a wide range of customized commercial services from supporting your drug product launch, commercial drug product manufacturing and/or specialized packaging of your drug product, to securing your supply chain with global serialization solutions.

• Commercial Product Launch & Distribution
• Oral Dose Commercial Manufacturing
• Oral Dose Commercial Packaging
  -Specialized Commercial Packaging
  -Vial / PFS / Autoinjector Labeling
  -Complex Kit Assembly
• Ultra Low Temperature Labeling & Packaging for gene and cell therapy products

RECENT INVESTMENTS

Almac has significantly enhanced the versatility of its analytical services to meet diverse demands through several key initiatives:

• Recent investment of £11 million to expand our global analytical services, creating over 100 new jobs. This expansion includes new laboratory spaces and upgrades to existing labs across Europe and the US, increasing overall capacity and capabilities.
• We have introduced specialised instrumentation and techniques, such as the Raman TRS100 system for faster analysis of tablets and capsules. Additional investment in the latest innovative physical sciences equipment includes XRPD, PSD, TGA, and DSC to support new offerings including spray drying for poorly soluble drug products.
• We offer a full suite of analytical testing for various product types, including small molecules, peptides, biologics, conjugates, and highly potent substances. This broad spectrum of services ensures we can handle diverse analytical challenges across all phases of drug development.
• Employing over 700 highly skilled analysts across multiple locations, we ensure that all testing is conducted with high accuracy and reliability. Continuous training and development programs further enhance our global team’s expertise.
• A multi-million-pound digitisation upgrade, including enhancements to our laboratory information management system (LIMS), allows for seamless information sharing across our multiple teams and facilities. This optimises our operations and improves service delivery.

WHY WORK WITH ALMAC?

Over 55 years’ experience serving > 600 clients, high level of repeat business

• Financial stability and long-term focus
• Focus on service integration to mitigate risk, reduce time and cost to market
• Quality driven and client focused
• Industry leading project management
• Committed to collaborative partnerships to achieve commercial success
• Prepared to invest in new solutions to meet clients’ ongoing needs